Impact of coronavirus pandemic on cancer patients; is it time for ectoine and/or ACE inhibitors?
<p>Cancer patients require attention after COVID-19. ACEI and/or ectoine could represent potential adjuvant therapy. Clinical trials are required to investigate this hope to mitigate COVID-19 infectivity and cell invasion.</p>
Saved in:
Main Author: | Eman El-Abd (Author) |
---|---|
Format: | Book |
Published: |
Journal of Gynecological Research and Obstetrics - Peertechz Publications,
2020-04-24.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Angioedema, an uncommon side effect of Ace-Inhibitor use
by: Shaista U Ahmed, et al.
Published: (2018) -
Are ACE inhibitors and ARBs more beneficial than harmful in the treatment of severe COVID-19 disease?
by: Christian A Devaux
Published: (2020) -
Coronavirus (COVID-19) pandemic: Outbreak, current scenario and impact on human physiology in Pakistan
by: Komal Jabeen, et al.
Published: (2021) -
Is it Time for the Introduction of Colostomy Free Survival in Rectal Cancer Patients
by: Mostafa El Haddad
Published: (2017) -
A survey on the impact of the coronavirus disease 2019 pandemic in Portuguese physical and rehabilitation medicine departments
by: Catarina A Branco, et al.
Published: (2021)